New AIDS vaccine trials underway in Atlanta.
Volunteers should begin getting shots any day now, said Don Hildebrand, the chief executive of GeoVax Inc., the Atlanta biotechnology firm that licensed the vaccine.
It's a phase one trial, in which healthy, uninfected volunteers are given low doses in a check for safety and immune response, Hildebrand said Friday.
A second, higher-dose trial -- with 36 people -- is expected to begin in a few months.
If these trials are successful, future trials will be done to see if the vaccine actually prevents the virus from causing AIDS, he said.
No comments:
Post a Comment